Sign in to fuzzto save your conversations, follow your research and come back anytime.
Fineotex Chemical
SectorChemicals
The Quarter story
The two most recent quarterly results, compared side-by-side.
Fineotex Chemical scales revenue and profit sharply, though rising costs and expenses compress margins.
Revenue surged from ₹137.07 Cr to ₹376.63 Cr from Q1 FY26 to Q1 FY27, showing strong top-line momentum.
Net profit margin slipped from 18.26% to 12.80% from Q1 FY26 to Q1 FY27, reflecting profit dilution.
Net profit grew from ₹25.03 Cr to ₹48.21 Cr from Q1 FY26 to Q1 FY27, confirming robust bottom-line expansion.
Raw material costs surged from ₹91.11 Cr to ₹243.23 Cr from Q1 FY26 to Q1 FY27, signaling severe input cost inflation.
Gross margin held steady from 33.53% to 35.42% from Q1 FY26 to Q1 FY27, indicating stable pricing power.
Employee benefit expenses jumped from ₹6.20 Cr to ₹26.83 Cr from Q1 FY26 to Q1 FY27, indicating aggressive headcount expansion.
EBITDA climbed from ₹25.20 Cr to ₹59.14 Cr from Q1 FY26 to Q1 FY27, signaling strong operational cash generation.
EBITDA margin fell from 18.38% to 15.70% from Q1 FY26 to Q1 FY27, showing ongoing margin compression.